每经AI快讯，诺普信（SZ 002215，收盘价：11.57元）11月25日晚间发布公告称，本次向特定对象发行 A股股票相关事项已经公司第七届董事会第九次会议（临时）审议通过，尚未取得公司股东会审议通 过。本次向特定对象发行股票的发行对象为不超过35名（含35名）的特定投资者，其中，公司本次向特 定对象发行的股票数量将按照募集资金总额除以发行价格确定，且不超过公司本次发行前总股本的 30%，即不超过约3.02亿股（含本数）。发行价格不低于定价基准日前20个交易日公司股票交易均价的 80%。本次发行拟募集不超过14.5亿元，募集资金用于以下用途：蓝莓基地新增扩建项目，总投资约 12.21亿元，拟投入募集资金11亿元；小浆果国际研发中心建设项目，总投资约2.74亿元，拟投入募集资 金1.5亿元；补充流动资金项目，总投资2亿元，拟投入募集资金2亿元。 2025年1至6月份，诺普信的营业收入构成为：产业链业务占比49.42%，农药制剂业务占比40.45%，田 田圈业务占比10.13%。 截至发稿，诺普信市值为116亿元。 每经头条（nbdtoutiao）——688496，被证监会立案！刚上市业绩就变脸，亏损超1亿元； ...

截至发稿，诺普信市值为116亿元。 每经头条（nbdtoutiao）——688496，被证监会立案！刚上市业绩就变脸，亏损超1亿元；核心产品受重 创：第一大客户"自产自用"，减少采购 （记者 张明双） 每经AI快讯，诺普信（SZ 002215，收盘价：11.57元）11月25日晚间发布公告称，公司第七届第九次董 事会临时会议于2025年11月24日在公司七楼会议室以现场结合通讯方式召开。会议审议了《关于公司 2025年度向特定对象发行股票方案论证分析报告的议案》等文件。 2025年1至6月份，诺普信的营业收入构成为：产业链业务占比49.42%，农药制剂业务占比40.45%，田 田圈业务占比10.13%。 ...

利尔化学所属申万行业为：基础化工-农化制品-农药。所属概念板块包括：生物农药、社保重仓、中 盘、融资融券等。 截至10月31日，利尔化学股东户数4.20万，较上期减少2.35%；人均流通股19008股，较上期增加 2.40%。2025年1月-9月，利尔化学实现营业收入67.09亿元，同比增长29.31%；归母净利润3.81亿元，同 比增长189.07%。 分红方面，利尔化学A股上市后累计派现14.96亿元。近三年，累计派现7.20亿元。 11月24日，利尔化学盘中下跌2.07%，截至11:22，报12.78元/股，成交1.54亿元，换手率1.48%，总市值 102.30亿元。 资金流向方面，主力资金净流出1212.78万元，特大单买入906.30万元，占比5.89%，卖出1930.64万元， 占比12.56%；大单买入2775.02万元，占比18.05%，卖出2963.46万元，占比19.27%。 利尔化学今年以来股价涨62.39%，近5个交易日跌4.77%，近20日涨0.55%，近60日涨3.31%。 今年以来利尔化学已经1次登上龙虎榜，最近一次登上龙虎榜为4月7日。 资料显示，利尔化学股份有限公司位于四川 ...

11月21日，中农联合跌5.01%，截至发稿，报16.87元/股，成交3541.21万元，换手率1.60%，总市值 24.04亿元。中农联合股价已经连续3天下跌，区间累计跌幅4.52%。 资料显示，山东中农联合生物科技股份有限公司位于中国(山东)自由贸易试验区济南片区经十路9999号 黄金时代广场A座14层，成立日期2006年12月19日，上市日期2021年4月6日，公司主营业务涉及农药原 药、中间体及制剂产品的研发、生产和销售。主营业务收入构成为：农药制剂52.97%，农药原药 44.83%，化工材料2.13%，其他0.07%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从中农联合十大流通股东角度 数据显示，诺安基金旗下1只基金位居中农联合十大流通股东。诺安多策略混合A（320016）三季度新 进十大流通股东，持有股数93.2万股，占流通股的比例为0.73%。根据测算，今日浮亏损失约82.95万 元。连续3天下跌期间浮亏损失78.29万元。 诺 ...

Core Viewpoint - Lier Chemical's stock has experienced a significant increase of 68.23% year-to-date, with recent trading showing mixed capital flows and a slight decline in share price on November 21 [1][2]. Company Overview - Lier Chemical Co., Ltd. is based in Chengdu, Sichuan Province, and was established on July 26, 2000, with its stock listed on July 8, 2008. The company specializes in the research, production, and sales of safe pesticides, including chlorinated pyridine, organophosphorus, sulfonylurea, and substituted urea [1]. - The revenue composition of Lier Chemical includes: 61.17% from pesticide raw materials, 21.31% from pesticide formulations, 9.09% from pesticide intermediates, 4.29% from agrochemical product circulation, 3.45% from chemical materials, 0.56% from environmental disposal, and 0.14% from other sources [1]. Financial Performance - For the period from January to September 2025, Lier Chemical achieved a revenue of 6.709 billion yuan, representing a year-on-year growth of 29.31%. The net profit attributable to shareholders was 381 million yuan, showing a remarkable increase of 189.07% compared to the previous year [2]. - Since its A-share listing, Lier Chemical has distributed a total of 1.496 billion yuan in dividends, with 720 million yuan distributed over the past three years [3]. Shareholder Structure - As of October 31, 2025, Lier Chemical had 42,000 shareholders, a decrease of 2.35% from the previous period. The average number of circulating shares per person increased by 2.40% to 19,008 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 13.308 million shares, an increase of 5.8814 million shares from the previous period. New shareholder Penghua China 50 Mixed Fund holds 5.256 million shares [3].

Group 1 - The company held its fifth board meeting on November 18, 2025, where all seven directors attended and voted on the agenda [2][5][3] - The board approved the acquisition of 70% equity in Jiangsu Heyutai Chemical Co., Ltd. for a cash consideration of 153.86 million yuan, funded by self-owned funds and bank loans [4][11][12] - The acquisition will allow Jiangsu Heyutai to become a wholly-owned subsidiary of the company, enhancing its product value chain and market position [11][15] Group 2 - Jiangsu Heyutai, established in June 2013, specializes in agricultural chemical products and has a registered capital of 120 million yuan [17][25] - The acquisition price was determined based on an asset appraisal that valued 100% of Jiangsu Heyutai's equity at 285.30 million yuan, with a 4.22% increase in value [28][30] - The company aims to leverage Jiangsu Heyutai's existing product lines and customer resources to enhance its operational efficiency and market reach [46][47] Group 3 - The transaction does not constitute a related party transaction or a major asset restructuring, and it does not require shareholder approval [12][16] - The company plans to implement measures to improve Jiangsu Heyutai's performance, which has shown signs of recovery after a period of losses [46][47] - The board's decision was supported by the strategic committee, ensuring compliance with legal and regulatory requirements [6][3]

Core Insights - Hailir's stock price increased by 2.01% on November 7, reaching 13.72 CNY per share, with a total market capitalization of 4.663 billion CNY [1] - The company has seen a year-to-date stock price increase of 15.29%, but a decline of 6.22% over the past 20 days and 9.08% over the past 60 days [1] - Hailir's main business involves the production and sales of pesticide formulations and active ingredients, with 97.46% of revenue coming from pesticides [1] Financial Performance - For the period from January to September 2025, Hailir reported a revenue of 3.391 billion CNY, representing a year-on-year growth of 5.50%, and a net profit attributable to shareholders of 208 million CNY, up 6.15% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 1.255 billion CNY, with 680 million CNY distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, Hailir had 13,000 shareholders, a decrease of 14.70% from the previous period, with an average of 26,229 circulating shares per shareholder, an increase of 17.23% [2] - The top ten circulating shareholders include new entrants such as招商量化精选股票发起式A and招商成长量化选股股票A, with significant holdings [3]

Group 1 - The core viewpoint of the news is that Noposion has shown a positive stock performance with a year-to-date increase of 17.74% and a recent uptick of 2.07% over the last 20 days [1][2] - As of November 6, Noposion's stock price reached 12.81 CNY per share, with a total market capitalization of 12.877 billion CNY [1] - The company has experienced a net outflow of main funds amounting to 747,900 CNY, while large orders accounted for 21.78% of total buying and 21.86% of total selling [1] Group 2 - Noposion, established on September 18, 1999, and listed on February 18, 2008, specializes in agricultural protection products and services, with a revenue composition that includes fresh consumption (49.14%), insecticides (18.67%), and fungicides (15.42%) [2] - For the period from January to September 2025, Noposion reported a revenue of 4.086 billion CNY, reflecting a year-on-year growth of 4.92%, and a net profit attributable to shareholders of 576 million CNY, up 18.03% [2] - The company has distributed a total of 1.767 billion CNY in dividends since its A-share listing, with 653 million CNY distributed over the past three years [3] Group 3 - As of September 30, 2025, Noposion had 35,400 shareholders, a decrease of 19.15% from the previous period, with an average of 22,194 circulating shares per shareholder, an increase of 23.68% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 22.3321 million shares, while new entrants include Huaxia Industry Prosperity Mixed A and Huaxia Excellent Growth Mixed A [3]

Group 1 - The core point of the news is that Yangnong Chemical experienced a decline of 5.19%, with its stock price at 63.76 yuan per share and a total market capitalization of 25.848 billion yuan [1] - Yangnong Chemical, established on December 10, 1999, and listed on April 25, 2002, specializes in the research, production, and sales of pesticide products [1] - The main revenue composition of Yangnong Chemical includes 58.64% from active ingredients, 20.65% from trading, 18.78% from formulations, and 1.93% from other sources [1] Group 2 - According to data, the Fuguo Agricultural Theme ETF (159825) has increased its holdings in Yangnong Chemical by 111,400 shares in the third quarter, bringing the total to 896,600 shares, which accounts for 2.67% of the fund's net value [2] - The Fuguo Agricultural Theme ETF was established on December 10, 2020, with a current scale of 2.415 billion yuan and has achieved a year-to-date return of 22.85% [2] - The fund manager, Zhang Shengxian, has been in position for 10 years and 156 days, with the best fund return during his tenure being 111.9% and the worst being -89.6% [3]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 86.10 CNY, based on a 21x PE ratio for 2025 [3][6]. Core Insights - The company's earnings per share (EPS) are projected to be 4.10 CNY, 4.89 CNY, and 5.94 CNY for the years 2025, 2026, and 2027 respectively, indicating a strong growth trajectory [3]. - The company has demonstrated a commitment to risk control, which has allowed it to navigate challenges in the South American market effectively [11]. - The report highlights a significant improvement in profitability, with a net profit of 334 million CNY in Q3 2025, reflecting a year-on-year growth of 109.13% [11]. Financial Summary - The company's revenue is expected to grow from 11,485 million CNY in 2023 to 19,900 million CNY in 2027, with a compound annual growth rate (CAGR) of approximately 14.5% [5][13]. - Operating profit is projected to increase from 945 million CNY in 2023 to 2,246 million CNY in 2027, with a notable growth rate of 248.7% in 2025 [5][13]. - The gross margin is expected to improve from 21.2% in 2023 to 21.9% in 2027, indicating ongoing operational efficiency [5][13]. - The net profit attributable to the parent company is forecasted to rise from 771 million CNY in 2023 to 1,668 million CNY in 2027, with a significant growth of 155.9% in 2025 [5][13].